Lunedì 28 Aprile 2025
Aggiornato: 12:37
10 ultim'ora clock BREAKING NEWS

CHIMICA E FARMACEUTICA

comunicato stampa

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule control, alongside lifestyle interventions, for reducing body weight, in overweight or obese adults, with BMI of 27-40 without comorbidities, The trial was conducted in 9 different centers across the Unit...

comunicato stampa

Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA

GUANGZHOU, China, Jan. 10, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that China National Medical Products Administration (NMPA) approved the Investigational New Drug (IND) application for its non-addictive pain relief drug FZ008-145.



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza